Complex 3D Models to Study Drug Targeting of Invadopodia

ISSN: 2212-6988 (Online)
ISSN: 2212-697X (Print)

Volume 4, 2 Issues, 2017

Download PDF Flyer

Clinical Cancer Drugs

This journal supports open access

Aims & ScopeAbstracted/Indexed in

Submit Abstracts Online Submit Manuscripts Online

Giulio Francia
The University of Texas
El Paso, TX

View Full Editorial Board

Subscribe Purchase Articles Order Reprints

Complex 3D Models to Study Drug Targeting of Invadopodia

Clinical Cancer Drugs, 1(2): 85-89.

Author(s): Njainday Pulo Jobe, Daniel Rosel, Ondrej Tolde, Jan Kosla and Jan Brabek.

Affiliation: Department of Cell Biology, Charles University, Vinicna 7, 12843, Prague, Czech Republic.


Metastasis is the main cause of death in cancer patients, and in spite of its significance, it is still incompletely understood. In order for cancer to be metastatic, it must undergo a sequence of events, termed as the metastatic cascade. The ability of cancer cells to migrate and invade surrounding tissue is a critical step in the metastasis and is often associated with the formation of specific cellular structures called invadopodia. Invadopodia are actin-based protrusions of tumour cells or transformed cells critically involved in protease secretion and targeting, and cytoskeletal rearrangements enabling cellular invasion. Anti-invadopodia therapy is a possible new field in anti-metastatic treatment. We propose here a novel model for drug discovery of anti-invadopodial compounds based on large scale screening of invadopodia formation in 2D setting followed by validation of the results in complex 3D matrices such as dermis-based matrix.


Cancer, drug development, invadopodia, invasiveness, metastasis, 3D, dermis-based matrices.

Purchase Online Order Reprints Order Eprints Rights and Permissions

Article Details

Volume: 1
Issue Number: 2
First Page: 85
Last Page: 89
Page Count: 5
DOI: 10.2174/2212697X113016660003
Price: $58

Related Journals

Webmaster Contact: Copyright © 2016 Bentham Science